Colin MacKay, CEO of Symbiosis Pharmaceutical Services assesses the trends driving parenteral manufacturing in this guest blog as featured on Contract Pharma.
“There are a number of factors that are influencing the growing demand for aseptically-processed parenteral products. The continued growth of the biotech sector and increased funding available are major drivers, while mergers and acquisitions within the contract manufacturing organization (CMO) space are changing the landscape and service options available for drug developers.
The article explores the trends that are fueling the demand for parenteral manufacturing, the changing structure of the CMO industry and the impact on biotech and small pharma companies needing to outsource their clinical manufacturing requirements.”
Read the full article here via Contract Pharma.